SALISBURY MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: J83021 | SALISBURY, SP2 7FD
Showing results 101-150 of 750
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Levetiracetam | 1,026 | 129.3K | £8.0K | +124.1% ▲ |
| Donepezil hydrochloride | 1,018 | 28.2K | £1.1K | +229.9% ▲ |
| Famotidine | 986 | 34.5K | £20.4K | +102.1% ▲ |
| Lisinopril | 986 | 46.8K | £1.2K | -10.0% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 986 | 82.5K | £3.3K | +221.8% ▲ |
| Budesonide | 968 | 2,848 | £30.0K | +78.6% ▲ |
| 937 | 158.6K | £6.1K | +97.5% ▲ | |
| Insulin glargine | 935 | 6,389 | £45.9K | +229.3% ▲ |
| 931 | 11.2K | £3.2K | +273.1% ▲ | |
| Other emollient preparations | 893 | 513.8K | £6.9K | +48.7% ▲ |
| Hydroxocobalamin | 883 | 933 | £2.0K | +83.5% ▲ |
| Hydroxychloroquine sulfate | 883 | 31.7K | £1.5K | +356.0% ▲ |
| 874 | 90.4K | £4.6K | +2,034.7% ▲ | |
| Alogliptin | 872 | 29.1K | £26.3K | +243.9% ▲ |
| Umeclidinium bromide/vilanterol | 871 | 989 | £30.5K | +346.7% ▲ |
| Ferrous sulfate | 870 | 33.4K | £1.1K | +69.2% ▲ |
| Buprenorphine | 868 | 3,696 | £11.4K | +136.9% ▲ |
| Bupivacaine hydrochloride | 865 | 865 | £2.8K | +1,709.3% ▲ |
| Promethazine hydrochloride | 862 | 17.7K | £2.3K | +141.2% ▲ |
| Mirabegron | 862 | 27.3K | £25.1K | +114.6% ▲ |
| Estriol | 861 | 16.6K | £7.0K | +304.6% ▲ |
| Loperamide hydrochloride | 837 | 82.1K | £2.7K | +259.4% ▲ |
| Warfarin sodium | 836 | 47.8K | £1.6K | +77.3% ▲ |
| Nicotine | 817 | 30.5K | £30.1K | +1,346.4% ▲ |
| Mometasone furoate | 817 | 926 | £7.2K | +103.5% ▲ |
| Eplerenone | 814 | 25.7K | £3.2K | +207.0% ▲ |
| Mebeverine hydrochloride | 802 | 64.5K | £2.0K | +158.3% ▲ |
| Trimethoprim | 791 | 24.2K | £1.5K | +287.1% ▲ |
| Quinine sulfate | 791 | 26.5K | £4.7K | +173.2% ▲ |
| 764 | 839 | £37.2K | +146.0% ▲ | |
| Methylphenidate hydrochloride | 741 | 28.4K | £23.7K | +186.9% ▲ |
| Aripiprazole | 724 | 19.5K | £2.7K | +184.5% ▲ |
| Fluticasone/umeclidinium/vilanterol | 716 | 820 | £34.7K | +205.4% ▲ |
| Risperidone | 716 | 23.5K | £3.6K | +183.0% ▲ |
| Sodium valproate | 712 | 103.0K | £13.3K | +123.9% ▲ |
| Fluticasone furoate | 707 | 731 | £5.0K | +265.0% ▲ |
| Carbamazepine | 703 | 89.4K | £5.0K | +136.9% ▲ |
| 694 | 317.2K | £4.4K | +163.1% ▲ | |
| Co-beneldopa (Benserazide/levodopa) | 690 | 100.5K | £6.9K | +356.4% ▲ |
| Mesalazine (Systemic) | 682 | 84.0K | £42.5K | +184.7% ▲ |
| Pantoprazole | 650 | 31.3K | £1.4K | +136.5% ▲ |
| Lactulose | 649 | 364.0K | £3.4K | +97.1% ▲ |
| 646 | 686 | £3.5K | +173.5% ▲ | |
| Oxycodone hydrochloride | 645 | 60.5K | £9.9K | +152.0% ▲ |
| Prochlorperazine maleate | 640 | 29.0K | £1.7K | +216.6% ▲ |
| Digoxin | 617 | 20.8K | £1.5K | +63.0% ▲ |
| Latanoprost and timolol | 616 | 12.9K | £7.0K | +706.8% ▲ |
| Pancreatin | 611 | 253.7K | £74.8K | +449.6% ▲ |
| Aciclovir | 605 | 30.7K | £1.4K | +306.8% ▲ |
| Mometasone furoate | 604 | 44.5K | £4.2K | +351.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.